Stock HLUN B H. LUNDBECK A/S
Add to a list
To use this feature you must be a member
Log inSign up

Company H. Lundbeck A/S

Equities

HLUN B

DK0061804770

Pharmaceuticals

Real-time Estimate Cboe Europe
Other stock markets
 10:18:02 29/05/2024 BST 		5-day change 1st Jan Change
37.07 DKK -0.19% Intraday chart for H. Lundbeck A/S -0.05% +13.25%
05-15 H LUNDBECK : Q1 beat adds momentum to the recent share price rally Alphavalue
05-15 Transcript : H. Lundbeck A/S, Q1 2024 Earnings Call, May 15, 2024

Business Summary

H Lundbeck A/S is a Denmark-based company active in the pharmaceuticals industry. It is engaged in the research, development, manufacture and marketing of pharmaceuticals for the treatment of brain disorders, such as Alzheimer’s disease, Bipolar disorder, depression, epilepsy, Huntington’s disease, Parkinson’s disease and schizophrenia. Its product portfolio includes: Cipralex for the treatment of depression and anxiety disorders, Ebixa for the treatment of Alzheimer’s disease, Azilect for the treatment of Parkinson’s disease, Xenazine for the treatment of Huntington’s disease and Sabril for the treatment of epilepsy, among others. The Company operates through a number of subsidiaries, such as Lundbeck SAS, Lundbeck GmbH, SIA Lundbeck Latvia and Lundbeck LLC.

Number of employees: 5,681

Sales per Business

DKK in Million2022Weight2023Weight Delta
Rexulti/Rxulti
22.7 %
3,890 21.3 % 4,525 22.7 % +16.32%
Brintellix/Trintellix
21.7 %
4,277 23.4 % 4,324 21.7 % +1.10%
Other Pharmaceuticals
16.3 %
3,000 16.4 % 3,244 16.3 % +8.13%
Abilify Maintena
16.0 %
2,964 16.2 % 3,187 16.0 % +7.52%
Cipralex/Lexapro
10.7 %
2,360 12.9 % 2,135 10.7 % -9.53%
Vyepti
8.5 %
1,004 5.5 % 1,697 8.5 % +69.02%
Sabril
1.7 %
636 3.5 % 336 1.7 % -47.17%
Reconciling Items
1.6 %
277 1.5 % 327 1.6 % +18.05%
Exceptional Items
0.7 %
-588 -3.2 % 137 0.7 % -123.30%

Sales per region

DKK in Million2022Weight2023Weight Delta
United States
49.4 %
9,102 49.9 % 9,829 49.4 % +7.99%
International
25.1 %
5,203 28.5 % 4,991 25.1 % -4.07%
Europe
23.2 %
4,237 23.2 % 4,614 23.2 % +8.90%
Reconciling Items
1.6 %
277 1.5 % 327 1.6 % +18.05%
Exceptional Items
0.7 %
-588 -3.2 % 137 0.7 % -123.30%
Denmark
0.1 %
15 0.1 % 14 0.1 % -6.67%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 796,592,888 266,877,323 ( 33.50 %) 3,264,112 ( 0.4098 %) 30.74 %
Stock B 10 199,148,222 39,236,567 ( 19.70 %) 466,028 ( 0.2340 %)

Shareholders

NameEquities%Valuation
Lundbeckfonden
66.00 %
525,751,306 66.00 % 2 566 M kr
Skagen AS (Investment Management)
0.5584 %
4,447,800 0.5584 % 22 M kr
Bankinter Gestión de Activos SA SGIIC
0.3720 %
2,963,575 0.3720 % 14 M kr
Sector Gamma AS
0.2322 %
1,850,000 0.2322 % 9 M kr
Evli Fund Management Co. Ltd.
0.2284 %
1,819,420 0.2284 % 9 M kr
Canaccord Genuity Wealth Ltd.
0.1822 %
1,450,997 0.1822 % 7 M kr
Danske Bank A/S (Investment Management)
0.1693 %
1,348,778 0.1693 % 7 M kr
Nykredit Bank A/S (Investment Management)
0.1258 %
1,002,230 0.1258 % 5 M kr
Niche Asset Management Ltd.
0.0712 %
567,000 0.0712 % 3 M kr
Zadig Asset Management LLP
0.0690 %
550,000 0.0690 % 3 M kr
NameEquities%Valuation
Lundbeckfonden
80.00 %
159,318,577 80.00 % 673 M kr
Nykredit Bank A/S (Investment Management)
0.4848 %
965,535 0.4848 % 4 M kr
Argenta Spaarbank NV
0.4555 %
907,125 0.4555 % 4 M kr
Danske Bank A/S (Investment Management)
0.1739 %
346,382 0.1739 % 1 M kr
Sparinvest SA (Denmark)
0.0996 %
198,424 0.0996 % 837 748 kr
UBS Asset Management (Deutschland) GmbH
0.0835 %
166,230 0.0835 % 701 825 kr
Dimensional Fund Advisors Ltd.
0.0803 %
159,996 0.0803 % 675 505 kr
Eika Kapitalforvaltning AS
0.0773 %
153,866 0.0773 % 649 624 kr
Niche Asset Management Ltd.
0.0502 %
100,000 0.0502 % 422 201 kr
State Street Global Advisors Ltd.
0.0213 %
42,383 0.0213 % 178 941 kr

Company contact information

H. Lundbeck A/S

Ottiliavej 9

2500, Valby

+45 36 30 13 11

http://www.lundbeck.com
address H. Lundbeck A/S(HLUN B)

Group companies

NameCategory and Sector
Lundbeck Insurance A/S

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals Wholesale

Sales per Business

Sales per region

Ratings for H. Lundbeck A/S

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
37.14 DKK
Average target price
39.96 DKK
Spread / Average Target
+7.59%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
H. LUNDBECK A/S Stock H. Lundbeck A/S
+13.25% 5.23B
MCKESSON CORPORATION Stock McKesson Corporation
+18.64% 71.4B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-6.00% 23.08B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+2.69% 8.55B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+9.32% 8.43B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-25.47% 7.46B
EBOS GROUP LIMITED Stock EBOS Group Limited
+1.58% 4.29B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+5.71% 3.89B
GALENICA AG Stock Galenica AG
+0.69% 4.03B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+20.58% 3.59B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. HLUN B Stock
  4. Company H. Lundbeck A/S